Shypd.aiThe largest open index of AI toolsProxima (formerly VantAI) is an AI-powered drug discovery platform that decodes and designs protein interactions. It offers an integrated discovery platform with complementary technologies to unlock the full potential of proximity modulator modality.
Trending
Also listed in
About
Proxima, formerly known as VantAI, is an advanced AI-powered platform dedicated to revolutionizing drug discovery by decoding and designing the interfaces of life. The platform's mission is to make protein interactions programmable, focusing on inducers, modulators, and blockers. It features an integrated discovery platform built with three complementary, phase-shifting technologies designed to unlock the full potential of the proximity modulator modality. Proxima actively works with industry leaders and has recently announced significant collaborations and funding rounds, including an $80 million seed round. The company also hosts a lecture series on Generative AI in Drug Discovery, showcasing its commitment to advancing scientific understanding and application in the field.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check vant.ai for current pricing.
FAQs
Trending
